Larimar Therapeutics News

H.C. Wainwright Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsNov 19 03:43 ET

Larimar Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow JonesNov 18 12:55 ET

Oppenheimer Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $26

Moomoo NewsNov 1 08:31 ET

Larimar Therapeutics Analyst Ratings

BenzingaOct 31 05:42 ET

Citi Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $14

Moomoo NewsOct 30 22:33 ET

H.C. Wainwright Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsOct 30 12:31 ET

LifeSci Capital Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $36

Moomoo NewsOct 30 12:31 ET

Leerink Partners Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsOct 28 08:36 ET

Oppenheimer Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $26

Moomoo NewsOct 16 08:34 ET

Larimar Therapeutics Initiated at Outperform by Oppenheimer

Dow JonesOct 16 05:19 ET

Oppenheimer Initiates Larimar Therapeutics(LRMR.US) With Buy Rating, Announces Target Price $26

Moomoo NewsOct 15 16:32 ET

Larimar Therapeutics Analyst Ratings

BenzingaOct 3 10:35 ET

Wedbush Initiates Larimar Therapeutics(LRMR.US) With Buy Rating, Announces Target Price $22

Moomoo NewsOct 3 07:34 ET

H.C. Wainwright Initiates Larimar Therapeutics(LRMR.US) With Buy Rating, Announces Target Price $15

Moomoo NewsOct 2 06:37 ET

Larimar Therapeutics Price Target Announced at $15.00/Share by HC Wainwright & Co.

Dow JonesOct 2 06:22 ET

JonesTrading Initiates Larimar Therapeutics(LRMR.US) With Buy Rating, Announces Target Price $14

Moomoo NewsSep 11 17:31 ET

Larimar Therapeutics Initiated at Outperform by Baird

Dow JonesSep 4 05:53 ET

Larimar Therapeutics Analyst Ratings

BenzingaSep 4 05:44 ET

Baird Initiates Larimar Therapeutics(LRMR.US) With Buy Rating, Announces Target Price $16

Moomoo NewsSep 3 17:31 ET

Analysts Offer Insights on Healthcare Companies: 2seventy Bio (TSVT), Illumina (ILMN) and Larimar Therapeutics (LRMR)

TipRanksAug 9 06:08 ET